|
|||||
|
|
Pharmacokinetics of Oral Formulations of Gepotidacin (GSK2140944), a Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor,in Healthy Adult and Adolescent Participants |
|
| Authors: | Aline Barth Mohammad Hossain Darin B. Brimhall Caroline R. Perry Courtney A. Tiffany Sherry Xu Etienne F. Dumont |
| Affiliation: | a GlaxoSmithKline, Collegeville, Pennsylvania, USA ; b PPD, Las Vegas, Nevada, USA |
| Abstract: | |
| Keywords: | |